Valuation IMPACT Therapeutics, Inc

Stocks

Delayed Hong Kong S.E. Other stock markets 23:32:50 2026-07-20 EDT			5-day change	1st Jan Change
12.76 ^HKD	-3.55%		-26.41%	-

07-20	Impact Therapeutics Announces Clinical Data for Senaparib, IMP4297, and IMP1707 Accepted for Poster Presentation at 2026 ESMO Congress	CI
06-07	Impact Therapeutics Nets HK$120 Million From Full Exercise of IPO Overallotment Option	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2026	2027	2028
Market Cap ¹	3,156	-	-
Change	-	-	-
Enterprise Value (EV) ¹	2,323	1,878	1,700
Change	-	-19.16%	-9.51%
P/E	-	-	-
PBR	-	-	-
PEG	-	-	-
Capitalization / Revenue	11.4x	3.35x	4.13x
EV / Revenue	8.37x	2x	2.22x
EV / EBITDA	-16.5x	4.42x	13.6x
EV / EBIT	-16.2x	4.46x	14x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ³	-	-	-
Rate of return	-	-	-
EPS ³	-	-	-
Distribution rate	-	-	-
Net sales ¹	277.5	941.3	763.9
EBITDA ¹	-140.6	424.5	124.9
EBIT ¹	-143.2	421.3	121.2
Net income	-	-	-
Net Debt ¹	-832.3	-1,277	-1,456
Reference price ³	13.23	13.23	13.23
Nbr of stocks (in thousands)	276,165	-	-
Announcement Date	-	-	-

¹HKD in Million²CNY in Million³

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
IMPACT THERAPEUTICS, INC	-	10.94x	-21.6x	-	493M
LONZA GROUP AG	34.29x	6.01x	18.57x	0.96%	49.18B
REVOLUTION MEDICINES, INC.	-23.34x	351.51x	-21.46x	-.--%	39.58B
BEONE MEDICINES AG	46.99x	4.73x	30.33x	-.--%	34.69B
IQVIA HOLDINGS INC.	25.1x	2.78x	12.03x	-.--%	34.42B
CELLTRION, INC.	27.15x	7.96x	19.98x	0.42%	27.11B
MEDPACE HOLDINGS, INC.	31.75x	5.12x	23.3x	-.--%	15.36B
EUROFINS SCIENTIFIC SE	24.41x	2.07x	9.09x	1.1%	14.05B
ICON PUBLIC LIMITED COMPANY	24.03x	1.91x	11.58x	-.--%	13.02B
Average	23.80x	43.67x	9.09x	0.31%	25.32B
Weighted average by Cap.	22.59x	65.03x	11.84x	0.33%